BridgeMD
New treatment option for Reading Disability
Official title Noninvasive Brain Stimulation to Enhance Reading Comprehension Ability in Adults
ClinicalTrials.gov ID: NCT05523505
What this study is testing
- What it's testing
- The goal of this project is to address the urgent need for effective, scalable adult literacy interventions by integrating breakthroughs in two separate fields: 1.) the brain network science of resilience to reading disorders and 2.) high-definition non-invasive brain network stimulation. This study will first establish the efficacy of a novel, noninvasive stimulation protocol on reading behavior and brain metrics; then will determine how stimulation-induced effects interact with baseline reading comprehension ability; and lastly, will identify whether stimulation-induced effects are more clinically-beneficial than canonical behavioral interventions.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- This study will be open to all right-handed, native English monolingual speakers, who meet eligibility criteria regardless of race, gender, minority...
You likely can't join if
- We will exclude individuals with a personal medical history of stroke or seizures or those taking medications specifically prescribed for the...
- previous diagnosis of Intellectual Disability;
- known uncorrectable visual impairment;
- documented hearing impairment greater than or equal to a 25 dB loss;
- medical contraindication to MRI procedures (e.g., metal devices);
- known IQ below 70;
See the full eligibility criteria
- This study will be open to all right-handed, native English monolingual speakers, who meet eligibility criteria regardless of race, gender, minority or socioeconomic status. Due to age-related differences in the...
- We will exclude individuals with a personal medical history of stroke or seizures or those taking medications specifically prescribed for the treatment of stroke or seizures. However, participants who are on medications...
- previous diagnosis of Intellectual Disability;
- known uncorrectable visual impairment;
- documented hearing impairment greater than or equal to a 25 dB loss;
- medical contraindication to MRI procedures (e.g., metal devices);
- known IQ below 70;
- a pervasive developmental disorder;
- any known neurologic pathology, including epilepsy, spina bifida, cerebral palsy, traumatic brain injury, and brain tumors;
- recent medical diagnosis of migraines;
- pregnancy;
- history of syncope;
- severe fatigue,
- bilingualism or low English proficiency;
- poor reading ability that will prevent completion of the tasks; and
- comorbid severe psychiatric disorders will be excluded;
- a personal medical history of stroke or seizures;
- hair styles that do not allow for proper EEG net fitting, or that pose potential risks for damage to EEG net
The study team makes the final eligibility decision.
Where it's taking place
- Nashville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nashville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.